Carrie A.FitzpatrickCarrie A. Fitzpatrick41.78927490000000-87.601250000000001812Fitzpatrick, Carrie A.Constitutional CytogeneticsCytogenomicsCancer CytogeneticsAutismPrenatal genetic diagnosisDr. Fitzpatrick is a Clinical Cytogeneticist and Molecular Geneticist with a focus in Constitutional disorders. Her clinical practice and diagnostic expertise also include Cytogenetics and Molecular Genomics of neoplastic disorders including hematologic malignancies and solid tumors.Associate Professorplugins:TwitterTwitterprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:trainingAtOrganizationeducational organizationprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipvivo:degreeEarneddegree earnedDepartmentvivo:educationalTrainingeducation and trainingEducational Trainingvivo:freetextKeywordkeywordsvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:majorFieldmajor field of degreevivo:overviewoverviewvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 100640427632188Ginat DT, Cipriani NA, Purakal A, Fitzpatrick C, Paral K, Krausz T, Pytel PHead and neck pathologyDisseminated Malignant Rhabdoid Tumor of the Head and Neck. Head Neck Pathol. 2017 Jun; 11(2):224-227.Head Neck Pathol2016-09-08T00:00:002016Disseminated Malignant Rhabdoid Tumor of the Head and Neck.D002292Disorders1134250.717085Carcinoma, Renal CellAuthorship 106444628681314Can NT, Lingen MW, Mashek H, McElherne J, Briese R, Fitzpatrick C, van Zante A, Cipriani NAHead and neck pathologyExpression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head Neck Pathol. 2018 Mar; 12(1):95-104.Head Neck Pathol2017-07-05T00:00:002017Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.D007680Disorders1406200.652811Kidney NeoplasmsObstetrics and Gynecology29698836Kang W, Kadri S, Puranik R, Wurst MN, Patil SA, Mujacic I, Benhamed S, Niu N, Zhen CJ, Ameti B, Long BC, Galbo F, Montes D, Iracheta C, Gamboa VL, Lopez D, Yourshaw M, Lawrence CA, Aisner DL, Fitzpatrick C, McNerney ME, Wang YL, Andrade J, Volchenboum SL, Furtado LV, Ritterhouse LL, Segal JPThe Journal of molecular diagnostics : JMDSystem for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management. J Mol Diagn. 2018 07; 20(4):522-532.J Mol Diagn2018-04-24T00:00:002018System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.Authorship 10798420Authorship 1137362Authorship 119359529973405Wu L, Bernal GM, Cahill KE, Pytel P, Fitzpatrick CA, Mashek H, Weichselbaum RR, Yamini BScience translational medicineBCL3 expression promotes resistance to alkylating chemotherapy in gliomas. Sci Transl Med. 2018 07 04; 10(448).Sci Transl Med2018-07-04T00:00:002018BCL3 expression promotes resistance to alkylating chemotherapy in gliomas.28864906Tran L, Fitzpatrick C, Cohn SL, Pytel PVirchows Archiv : an international journal of pathologyComposite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology. Virchows Arch. 2017 Oct; 471(4):553-557.Virchows Arch2017-09-01T00:00:002017Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.29296715Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, Niu N, Weiner H, Thirman M, Stock W, Smith SM, Nabhan C, Segal JP, Lu P, Wang YLBlood advancesClonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017 May 09; 1(12):715-727.Blood Adv2017-05-02T00:00:002017Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL.Authorship 127053430698790Parilla M, Kadri S, Patil SA, Fitzpatrick C, Ritterhouse L, Segal J, Collins J, Pytel PJournal of neuropathology and experimental neurologyIntegrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations. J Neuropathol Exp Neurol. 2019 03 01; 78(3):257-267.J Neuropathol Exp Neurol2019-03-01T00:00:002019Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.2003University of Illinois at ChicagoUniversity of Illinois at Chicago, Molecular GeneticsPhDMolecular Genetics2007University of ChicagoUniversity of Chicago, CytogeneticsABMGG Clinical Fellowship Cytogenetics2017University of ChicagoUniversity of Chicago, Molecular GeneticsABMGG Clinical Fellowship Molecular GeneticsAuthorship 128567730910787Godfrey J, Tumuluru S, Bao R, Leukam M, Venkataraman G, Phillip J, Fitzpatrick C, McElherne J, MacNabb BW, Orlowski R, Smith SM, Kline JBloodPD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype. Blood. 2019 05 23; 133(21):2279-2290.Blood2019-03-25T00:00:002019PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.Authorship 128954830986793Parilla M, Alikhan M, Al-Kawaaz M, Patil S, Kadri S, Ritterhouse LL, Segal J, Fitzpatrick C, Antic TThe American journal of surgical pathologyGenetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma. Am J Surg Pathol. 2019 08; 43(8):1135-1144.Am J Surg Pathol2019-08-01T00:00:002019Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma.Authorship 129172631021855Cipriani NA, Lusardi JJ, McElherne J, Pearson AT, Olivas AD, Fitzpatrick C, Lingen MW, Blair EAThe American journal of surgical pathologyMucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897.Am J Surg Pathol2019-07-01T00:00:002019Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis.Authorship 130422631231127Chapel DB, Schulte JJ, Berg K, Churg A, Dacic S, Fitzpatrick C, Galateau-Salle F, Hiroshima K, Krausz T, Le Stang N, McGregor S, Nabeshima K, Husain ANModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncMTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020 02; 33(2):245-254.Mod Pathol2019-06-23T00:00:002019MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma.Authorship 1346891231822802Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, Hartmann S, Venkataraman GModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncDiagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020 05; 33(5):834-845.Mod Pathol2019-12-10T00:00:002019Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities.Authorship 135617532026294Limbach AL, Lingen MW, McElherne J, Mashek H, Fitzpatrick C, Hyjek E, Mostofi R, Cipriani NAHead and neck pathologyThe Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma. Head Neck Pathol. 2020 Dec; 14(4):889-898.Head Neck Pathol2020-02-05T00:00:002020The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.AymanAl-HendyAyman Al-Hendy41.7886000000000087.598699999999993954Al-Hendy, AymanProfessorD014408Chemicals & Drugs32614610.548098Biomarkers, TumorJeremySegalJeremy Segal0.000000000000000.000000000000002880Segal, JeremyProfessorMedicine-Hematology and OncologyD017404Procedures1463480.913343In Situ Hybridization, FluorescenceAuthorship 152224435034039Paintal A, Tjota MY, Wang P, Fitzpatrick C, Wanjari P, Stadler WM, Gallan AJ, Segal J, Antic TThe American journal of surgical pathologyNF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases. Am J Surg Pathol. 2022 05 01; 46(5):617-627.Am J Surg Pathol2022-05-01T00:00:002022NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases.Authorship 1542071535419889DeRoin L, Cavalcante de Andrade Silva M, Petras K, Arndt K, Phillips N, Wanjari P, Subramanian HP, Montes D, McElherne J, Theissen M, Briese R, Das S, Godley LA, Segal J, Del Gaudio D, Fitzpatrick C, Churpek JEHuman mutationFeasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders. Hum Mutat. 2022 07; 43(7):950-962.Hum Mutat2022-04-14T00:00:002022Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders.D059014Procedures2084550.757959High-Throughput Nucleotide SequencingAuthorship 6378411Authorship 637851Authorship 637863Authorship 6378710Authorship 63788524689074Cheng YW, Tan CA, Minor A, Arndt K, Wysinger L, Grange DK, Kozel BA, Robin NH, Waggoner D, Fitzpatrick C, Das S, Del Gaudio DMolecular genetics & genomic medicineCopy number analysis of NIPBL in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion. Mol Genet Genomic Med. 2014 Mar; 2(2):115-23.Mol Genet Genomic Med2013-11-14T00:00:002013Copy number analysis of NIPBL in a cohort of 510 patients reveals rare copy number variants and a mosaic deletion.12223407Fitzpatrick CA, Sharkov NV, Ramsay G, Katzen ALDevelopment (Cambridge, England)Drosophila myb exerts opposing effects on S phase, promoting proliferation and suppressing endoreduplication. Development. 2002 Oct; 129(19):4497-507.Development2002-10-01T00:00:002002Drosophila myb exerts opposing effects on S phase, promoting proliferation and suppressing endoreduplication.21817904Jennings LJ, Yu M, Fitzpatrick C, Smith FADiagnostic molecular pathology : the American journal of surgical pathology, part BValidation of multiplex ligation-dependent probe amplification for confirmation of array comparative genomic hybridization. Diagn Mol Pathol. 2011 Sep; 20(3):166-74.Diagn Mol Pathol2011-09-01T00:00:002011Validation of multiplex ligation-dependent probe amplification for confirmation of array comparative genomic hybridization.23273872Amburgey K, Lawlor MW, Del Gaudio D, Cheng YW, Fitzpatrick C, Minor A, Li X, Aughton D, Das S, Beggs AH, Dowling JJNeuromuscular disorders : NMDLarge duplication in MTM1 associated with myotubular myopathy. Neuromuscul Disord. 2013 Mar; 23(3):214-8.Neuromuscul Disord2012-12-28T00:00:002012Large duplication in MTM1 associated with myotubular myopathy.16906162Sharp AJ, Hansen S, Selzer RR, Cheng Z, Regan R, Hurst JA, Stewart H, Price SM, Blair E, Hennekam RC, Fitzpatrick CA, Segraves R, Richmond TA, Guiver C, Albertson DG, Pinkel D, Eis PS, Schwartz S, Knight SJ, Eichler EENature geneticsDiscovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nat Genet. 2006 Sep; 38(9):1038-42.Nat Genet2006-08-13T00:00:002006Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome.36655425Roloff GW, Wen F, Ramsland A, Artz AS, Kosuri S, Stock W, Odenike O, Larson RA, Liu H, Godley LA, Thirman MJ, Patel AA, Daugherty CK, DuVall AS, Nawas MT, Dworkin E, Wool GD, Gurbuxani S, Fitzpatrick C, Segal JP, Wang P, Drazer MWHaematologicaClinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.Haematologica2023-08-01T00:00:002023Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.Authorship 15831110Authorship 1590454Authorship 1599871936592877Tjota MY, Sharma A, Wanjari P, Fitzpatrick C, Segal J, Antic THuman pathologyTSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases. Hum Pathol. 2023 04; 134:124-133.Hum Pathol2022-12-30T00:00:002022TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.35973200Godfrey J, Liu H, Yu J, Tallarico M, Curran E, Artz A, Riedell PA, Stock W, Karrison T, Fitzpatrick C, Venkataraman G, Cooper A, Smith SM, Bishop MR, Kline JBlood advancesPembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.Blood Adv2023-03-28T00:00:002023Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.http://headandneckpathology.com/Head and Neck Pathologyhttps://voices.uchicago.edu/grosspathology/Gross Pathologyhttp://naglerlab.uchicago.eduNagler Lab@nicolecipriani@CathyNaglerCanerSayginCaner Saygin41.7886000000000087.598699999999994321Saygin, CanerAssistant ProfessorMedicinePathologyUniversity of ChicagoPeterPytelx3JwH6QZOfnamXNnYUHhvWD+6g==Peter Pytel41.78927490000000-87.601250000000001091Pytel, PeterProfessorAuthorship 166894437796179Mendoza RP, Wang P, Smith HL, Fitzpatrick CA, Haridas R, Wanjari P, Briese R, Shahid A, McCluggage WG, Bennett JAThe American journal of surgical pathologyClinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors. Am J Surg Pathol. 2023 12 01; 47(12):1398-1408.Am J Surg Pathol2023-10-05T00:00:002023Clinicopathologic Analysis and Molecular Profiling of Ovarian Steroid Cell Tumors.MohamedEldibanyMohamed Eldibany41.78927490000000-87.6012500000000015Eldibany, MohamedClinical Assistant ProfessorTatjanaAnticTatjana Antic41.78927490000000-87.601250000000001672Antic, TatjanaProfessor0.7493650.0126824193research areas0.810180.030462547coauthor of19.25733.559360similar to1132selected publicationsWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.ProfessorHansSchreiberHans Schreiber41.78927490000000-87.601250000000001921Schreiber, HansProfessorRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, ProfessorCathryn R.Nagler1GxoDK0QC8zbgn4qdUXm+mb7+MTz7LFLCathryn R. Nagler41.78927490000000-87.601250000000002059Nagler, Cathryn R.ProfessorTabaKheradmandTaba Kheradmand41.78927490000000-87.601250000000002264Kheradmand, TabaPostdoctoral ScholarYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, ProfessorMartinWeigertMartin Weigert41.78927490000000-87.60125000000000931Weigert, MartinPROFESSOR38039510Johnston H, Youshanlouei HR, Osei C, Patel AA, DuVall A, Wang P, Wanjari P, Segal J, Venkataraman G, Cheng JX, Gurbuxani S, Lager A, Fitzpatrick C, Thirman M, Nawas M, Liu H, Drazer M, Odenike O, Larson R, Stock W, Saygin CBlood advancesSocioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults. Blood Adv. 2024 01 09; 8(1):164-171.Blood Adv2024-01-09T00:00:002024Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.Authorship 16853413Authorship 168602338150184Saygin C, Zhang P, Stauber J, Aldoss I, Sperling AS, Weeks LD, Luskin MR, Knepper TC, Wanjari P, Wang P, Lager AM, Fitzpatrick C, Segal JP, Gharghabi M, Gurbuxani S, Venkataraman G, Cheng JX, Eisfelder BJ, Bohorquez O, Patel AA, Umesh Nagalakshmi S, Jayaram S, Odenike OM, Larson RA, Godley LA, Arber DA, Gibson CJ, Munshi NC, Marcucci G, Ebert BL, Greally JM, Steidl U, Lapalombella R, Shah BD, Stock WBlood cancer discoveryAcute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis. Blood Cancer Discov. 2023 Dec 27.Blood Cancer Discov2023-12-27T00:00:002023Acute lymphoblastic leukemia with myeloid mutations is a high-risk disease associated with clonal hematopoiesis.Authorship 16920912https://voices.uchicago.edu/sayginlab/Saygin Labtrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Postdoctoral ScholarPostdoctoral Scholartrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Clinical Assistant ProfessorClinical Assistant Professortrue1PROFESSORPROFESSORtrue1ProfessorProfessor1010Chicago60637ILAuthorship 893191126894574Alkorta-Aranburu G, Sukhanova M, Carmody D, Hoffman T, Wysinger L, Keller-Ramey J, Li Z, Johnson AK, Kobiernicki F, Botes S, Fitzpatrick C, Das S, Del Gaudio DJournal of pediatric endocrinology & metabolism : JPEMImproved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach. J Pediatr Endocrinol Metab. 2016 May 01; 29(5):523-31.J Pediatr Endocrinol Metab2016-05-01T00:00:002016Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach.Authorship 90643527044931Choudhury NJ, Campanile A, Antic T, Yap KL, Fitzpatrick CA, Wade JL, Karrison T, Stadler WM, Nakamura Y, O'Donnell PHJournal of clinical oncology : official journal of the American Society of Clinical OncologyAfatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations. J Clin Oncol. 2016 06 20; 34(18):2165-71.J Clin Oncol2016-04-04T00:00:002016Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations.Authorship 91175327173781Lan TT, Keller-Ramey J, Fitzpatrick C, Kadri S, Taxy JB, Segal JP, Furtado LV, Antic TVirchows Archiv : an international journal of pathologyUnclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block. Virchows Arch. 2016 Jul; 469(1):81-91.Virchows Arch2016-05-12T00:00:002016Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block.Nicole A.CiprianiNicole A. Cipriani0.000000000000000.000000000000002756Cipriani, Nicole A.ProfessorAuthorship 96013827771374McGregor SM, McElherne J, Minor A, Keller-Ramey J, Dunning R, Husain AN, Vigneswaran W, Fitzpatrick C, Krausz THuman pathologyBAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. Hum Pathol. 2017 02; 60:86-94.Hum Pathol2016-10-19T00:00:002016BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.Authorship 972041427836695Kadri S, Long BC, Mujacic I, Zhen CJ, Wurst MN, Sharma S, McDonald N, Niu N, Benhamed S, Tuteja JH, Seiwert TY, White KP, McNerney ME, Fitzpatrick C, Wang YL, Furtado LV, Segal JPThe Journal of molecular diagnostics : JMDClinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. J Mol Diagn. 2017 01; 19(1):43-56.J Mol Diagn2016-11-09T00:00:002016Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.Authorship 994941028104920Guidugli L, Johnson AK, Alkorta-Aranburu G, Nelakuditi V, Arndt K, Churpek JE, Godley LA, Townsley D, Young NS, Fitzpatrick C, Del Gaudio D, Das S, Li ZLeukemiaClinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes. Leukemia. 2017 05; 31(5):1226-1229.Leukemia2017-01-20T00:00:002017Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.